Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients. [electronic resource]
Producer: 20061024Description: 383-8 p. digitalISSN:- 0024-7758
- Cisplatin -- therapeutic use
- Combined Modality Therapy -- adverse effects
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Humans
- Hysterectomy
- Lymph Node Excision
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Staging
- Radiotherapy, Adjuvant
- Retrospective Studies
- Survival Rate
- Time Factors
- Uterine Cervical Neoplasms -- mortality
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.